A U.S. advisory panel has found Doribax, an antibiotic produced by Johnson & Johnson, to be effective in treating patients with hospital-acquired pneumonia. The drug is already being used in hospitals to treat abdominal and urinary tract infections.
A U.S. advisory panel has found Doribax, an antibiotic produced by Johnson & Johnson, to be effective in treating patients with hospital-acquired pneumonia. The drug is already being used in hospitals to treat abdominal and urinary tract infections.